Literature DB >> 2840891

Syncatalytic inactivation of prolyl 4-hydroxylase by anthracyclines.

V Günzler1, H M Hanauske-Abel, R Myllylä, D D Kaska, A Hanauske, K I Kivirikko.   

Abstract

The anthracyclines doxorubicin and daunorubicin were found to act as irreversible inhibitors of prolyl 4-hydroxylase. The reaction rate for enzyme from both chick and human origin was first order, the concentration of inhibitor giving 50% inhibition being 60 microM for both compounds after 1 h. The effect was dependent on the presence of iron ions in the reaction mixture. Inactivation could be prevented by addition of high concentrations of ascorbate, but not 2-oxoglutarate, before the inactivation period. The same results were obtained with competitive analogues of these cosubstrates. Lysyl hydroxylase from chick embryos was also susceptible to inactivation. Its activity was decreased by 50% after incubation for 1 h with a 150 microM concentration of the inhibitors. When chick-embryo prolyl 4-hydroxylase was incubated with [14-14C]doxorubicin, both enzyme subunits were radioactively labelled, about 70% of the total radioactivity being found in the alpha-subunit. Since the anthracyclines are known to undergo a redox reaction generating semiquinone radicals with Fe3+ only, the results suggest that the enzyme-bound iron ion is oxidized to a tervalent intermediate in uncoupled reaction cycles. The data also suggest that both enzyme subunits contribute to the catalytic site of prolyl 4-hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840891      PMCID: PMC1149011          DOI: 10.1042/bj2510365

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  One-electron reduction of adriamycin: properties of the semiquinone.

Authors:  E J Land; T Mukherjee; A J Swallow; J M Bruce
Journal:  Arch Biochem Biophys       Date:  1983-08       Impact factor: 4.013

2.  Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes.

Authors:  K I Kivirikko; R Myllylä
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.

Authors:  K J Davies; J H Doroshow; P Hochstein
Journal:  FEBS Lett       Date:  1983-03-07       Impact factor: 4.124

4.  An improved method for the purification of vertebrate prolyl hydroxylase by affinity chromatography.

Authors:  N L Kedersha; R A Berg
Journal:  Coll Relat Res       Date:  1981-07

5.  Prolyl 4-hydroxylase activity in relation to the oxidation state of enzyme-bound iron. The role of ascorbate in peptidyl proline hydroxylation.

Authors:  L de Jong; S P Albracht; A Kemp
Journal:  Biochim Biophys Acta       Date:  1982-06-04

6.  Solution chemistry studies of adriamycin--iron complexes present in vivo.

Authors:  P M May; G K Williams; D R Williams
Journal:  Eur J Cancer       Date:  1980-09       Impact factor: 9.162

7.  The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion.

Authors:  K Majamaa; H M Hanauske-Abel; V Günzler; K I Kivirikko
Journal:  Eur J Biochem       Date:  1984-01-16

8.  Oxidative destruction of DNA by the adriamycin-iron complex.

Authors:  H Eliot; L Gianni; C Myers
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

9.  Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase.

Authors:  R Myllylä; K Majamaa; V Günzler; H M Hanauske-Abel; K I Kivirikko
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

10.  The function of ascorbate with respect to prolyl 4-hydroxylase activity.

Authors:  J J Nietfeld; A Kemp
Journal:  Biochim Biophys Acta       Date:  1981-01-15
View more
  8 in total

1.  The catalytic mechanism of the hydroxylation reaction of peptidyl proline and lysine does not require protein disulphide-isomerase activity.

Authors:  R Myllylä; D D Kaska; K I Kivirikko
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

Review 2.  Collagen Prolyl 4-Hydroxylase as a Therapeutic Target.

Authors:  James D Vasta; Ronald T Raines
Journal:  J Med Chem       Date:  2018-07-23       Impact factor: 7.446

3.  Modification of vertebrate and algal prolyl 4-hydroxylases and vertebrate lysyl hydroxylase by diethyl pyrocarbonate. Evidence for histidine residues in the catalytic site of 2-oxoglutarate-coupled dioxygenases.

Authors:  R Myllylä; V Günzler; K I Kivirikko; D D Kaska
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

4.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.

Authors:  Mircea Ivan; Thomas Haberberger; David C Gervasi; Kristen S Michelson; Volkmar Günzler; Keiichi Kondo; Haifeng Yang; Irina Sorokina; Ronald C Conaway; Joan W Conaway; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-26       Impact factor: 11.205

5.  Polyclonal and monoclonal antibodies to human lysyl hydroxylase and studies on the molecular heterogeneity of the enzyme.

Authors:  R Myllylä; L Pajunen; K I Kivirikko
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

6.  Prolyl 4-hydroxylase from Volvox carteri. A low-Mr enzyme antigenically related to the alpha subunit of the vertebrate enzyme.

Authors:  D D Kaska; R Myllylä; V Günzler; A Gibor; K I Kivirikko
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 7.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

8.  Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases.

Authors:  Ravi Kant; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.